Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis

Objective To examine the safety, effectiveness, and cost effectiveness of long acting insulin for type 1 diabetes. Design Systematic review and network meta-analysis. Data sources Medline, Cochrane Central Register of Controlled Trials, Embase, and grey literature were searched through January 2013....

Descripción completa

Detalles Bibliográficos
Autores principales: Tricco, Andrea C, Ashoor, Huda M, Antony, Jesmin, Beyene, Joseph, Veroniki, Areti Angeliki, Isaranuwatchai, Wanrudee, Harrington, Alana, Wilson, Charlotte, Tsouros, Sophia, Soobiah, Charlene, Yu, Catherine H, Hutton, Brian, Hoch, Jeffrey S, Hemmelgarn, Brenda R, Moher, David, Majumdar, Sumit R, Straus, Sharon E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199252/
https://www.ncbi.nlm.nih.gov/pubmed/25274009
http://dx.doi.org/10.1136/bmj.g5459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199252/
https://www.ncbi.nlm.nih.gov/pubmed/25274009
http://dx.doi.org/10.1136/bmj.g5459

Ejemplares similares